ArticleImmunologic research2026
From PD-L1 downregulation to biomarker-driven immunotherapy design: advancing translational application of SALL4-targeted PEN-FFW in breast cancer.
M Vijayasimha et al.PubMed ↗Publisher ↗
No numbers read from the abstract.